The results for the year were significantly impacted by a reduction in sales of approximately £2.0 million compared to 2024, while maintaining a largely unchanged cost structure. In addition, the write-off of the debtor balance relating to Adapa Ireland (£188k), together with the clean-up of accounts payable balances, which resulted in a negative foreign exchange impact of £175k, contributed to an overall loss before tax for the year of £592k.
For 2026, the Company has budgeted net sales of £10.3 million, representing an increase of approximately £320k over 2025. Margins are expected to remain at a similar level, which is anticipated to return the business to a break-even position.
The Company’s financial instruments, other than derivatives, comprise borrowings, cash and liquid resources, together with various items arising directly from operations, including trade debtors and trade creditors. The primary purpose of these financial instruments is to finance the Company’s operations.
The Company is exposed to the normal credit risk associated with potential non-payment by customers. However, these risks are mitigated through partial credit insurance arrangements and ongoing credit assessments, ensuring that such exposures do not threaten the Company’s financial stability.
As at May 2025, the Company had not entered into any derivative transactions. However, following the planned closure of the St Helens operation, purchases will increasingly be sourced from other Adapa entities, which predominantly invoice in Euros. As a result, management will assess whether it is appropriate to reintroduce derivative instruments to manage foreign exchange exposure.
Management’s focus for the coming years will be on increasing sales volumes while reducing cost of goods sold. These measures are expected to establish a stronger and sustainable foundation for the Company to return to profitability.